ASP Isotopes Inc. ASPI

Healthcare SIC 2890 - Miscellaneous Chemical Products NAICS Manufacturing › Chemical Manufacturing derived Nasdaq

We are an advanced materials company dedicated to the development of a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. In addition, in January 2026, we acquired Renergen, which is South Africa's leading onshore natural gas explorer and the first integrated producer of both liquid helium and LNG (as discussed further below). Our proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to enable the production of isotopes for a range of industrial and advanced technology applications. Our initial focus with respect to our isotope enrichment platform is on the production and commercialization of enriched Carbon-14 ("C-14"), Silicon-28 ("Si-28") and Ytterbium-176 ("Yb-176").

Last close 1.95 2026-10-23
Market cap $298.2M 2026-06-30 share count
52-week range 1.89 - 11.22

Valuation FY2025 figures against the last close

P/S12.5x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield0.0%
Diluted EPS-2.11

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Construction services
  • Specialist isotopes and related services
  • Other
Revenue by segment, 3 categories over 1 years. The same figures are in the table below. FY2025 Construction services, FY2025: 18.2M (76.2%) 76% Construction services Specialist isotopes and related services, FY2025: 5.7M (23.8%) 24% Other, FY2025: 0 (0.0%)
Segment FY2025
Construction services $18.2M
Specialist isotopes and related services $5.7M
Other $0

As the company reported it, from the “Revenue and Segment Information (Details 5)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021
Revenue $23.8M$4.1M$433.0K$0—
Cost of revenue $20.4M$2.5M$294.1K$0—
Gross profit $3.4M$1.6M$139.0K$0—
R&D $12.4M$3.1M$764.6K$1.3M—
SG&A $48.2M$24.8M$15.4M$3.8M—
Total operating expenses $63.3M$28.0M$16.2M$5.1M—
Operating income -$59.9M-$26.4M-$16.0M-$5.1M—
Interest expense $575.0K$259.0K$118.5K$0—
Pre-tax income -$159.6M-$32.3M-$16.3M-$4.9M—
Income tax $282.0K$111.0K$6.1K$0—
Net income -$159.8M-$32.4M-$16.3M-$4.9M—
EPS, basic -2.11-0.63-0.49-0.18—
EPS, diluted -2.11-0.63-0.49——
Shares, diluted (wtd. avg.) 83.0M55.7M33.1M26.8M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021
Cash and equivalents $285.6M$61.9M$7.9M$2.4M$3.0M
Short-term investments $47.7M$0———
Inventory $1.1M$66.0K$0——
Total current assets $399.9M$65.7M$10.5M$3.3M$3.2M
Property, plant and equipment $33.5M$22.4M$10.7M$8.2M$3.0M
Goodwill $8.6M$3.2M$3.3M$0—
Other intangibles $1.5M————
Total assets $498.0M$94.3M$27.5M$12.5M$7.1M
Accounts payable $5.8M$1.0M$2.0M$354.0K$59.7K
Short-term debt $12.9M$939.0K———
Total current liabilities $32.7M$7.1M$5.7M$1.9M$303.4K
Long-term debt $1.5M$1.4M———
Total liabilities $235.1M$43.2M$8.7M$2.7M$1.1M
Retained earnings -$231.3M-$56.2M-$23.8M-$7.6M-$2.6M
Total equity $204.2M$47.9M$18.8M$9.8M$6.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021
Operating cash flow -$37.8M-$16.7M-$5.4M-$2.9M—
Depreciation and amortisation $1.9M$471.0K$37.4K$0—
Stock-based compensation $16.0M$8.6M$8.7M$2.0M—
Capital expenditure $9.7M$9.7M$2.3M$4.5M—
Investing cash flow -$110.8M-$11.4M-$2.5M-$4.5M—
Financing cash flow $371.6M$82.5M$13.4M$6.6M—
Dividends paid $0$2.8M$0——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-197329.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -200M -150M -100M -50M 0 50M Revenue, FY2022: 0 Gross profit, FY2022: 0 Net income, FY2022: -4.9M Revenue, FY2023: 433K Gross profit, FY2023: 139K Net income, FY2023: -16.3M Revenue, FY2024: 4.1M Gross profit, FY2024: 1.6M Net income, FY2024: -32.4M Revenue, FY2025: 23.8M Gross profit, FY2025: 3.4M Net income, FY2025: -159.8M FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2021FY2022FY2023FY2024FY2025
Revenue — $0 $433.0K $4.1M $23.8M
Gross profit — $0 $139.0K $1.6M $3.4M
Net income — -$4.9M -$16.3M -$32.4M -$159.8M

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2890

TickerCompanyMarket capP/ERevenue growth
ESI Element Solutions Inc $8.09B 42.0x 3.8%
CBT CABOT CORP $3.81B 12.3x -7.0%
WDFC WD 40 CO $2.85B 31.8x 5.0%
FTK FLOTEK INDUSTRIES INC/CN/ $865.7M 28.5x 26.9%
OEC Orion S.A. $308.0M — -3.8%
FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC $81.9M 106.8x 0.7%
ARQ Arq, Inc. $76.4M — 10.4%
ZTEK Zentek Ltd. — — —